BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38810562)

  • 1. An artificial intelligence-assisted clinical framework to facilitate diagnostics and translational discovery in hematologic neoplasia.
    Tang M; Antić Ž; Fardzadeh P; Pietzsch S; Schröder C; Eberhardt A; van Bömmel A; Escherich G; Hofmann W; Horstmann MA; Illig T; McCrary JM; Lentes J; Metzler M; Nejdl W; Schlegelberger B; Schrappe M; Zimmermann M; Miarka-Walczyk K; Pastorczak A; Cario G; Renard BY; Stanulla M; Bergmann AK
    EBioMedicine; 2024 Jun; 104():105171. PubMed ID: 38810562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia.
    Schieck M; Lentes J; Thomay K; Hofmann W; Behrens YL; Hagedorn M; Ebersold J; Davenport CF; Fazio G; Möricke A; Buchmann S; Alten J; Cario G; Schrappe M; Bergmann AK; Stanulla M; Steinemann D; Schlegelberger B; Cazzaniga G; Göhring G
    Ann Hematol; 2020 Apr; 99(4):809-818. PubMed ID: 32078009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interphase-FISH screening for eight common rearrangements in pediatric B-cell precursor acute lymphoblastic leukemia.
    Hutspardol S; Pakakasama S; Kanta K; Nuntakarn L; Anurathapan U; Sirachainan N; Songdej D; Sawangpanich R; Tiyasirichokchai R; Rerkamnuaychoke B; Hongeng S
    Int J Lab Hematol; 2013 Aug; 35(4):406-15. PubMed ID: 23190578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.
    Li JF; Dai YT; Lilljebjörn H; Shen SH; Cui BW; Bai L; Liu YF; Qian MX; Kubota Y; Kiyoi H; Matsumura I; Miyazaki Y; Olsson L; Tan AM; Ariffin H; Chen J; Takita J; Yasuda T; Mano H; Johansson B; Yang JJ; Yeoh AE; Hayakawa F; Chen Z; Pui CH; Fioretos T; Chen SJ; Huang JY
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11711-E11720. PubMed ID: 30487223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia.
    Gudapati P; Khanka T; Chatterjee G; Ghogale S; Badrinath Y; Deshpande N; Patil J; Narula G; Shetty D; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
    Cytometry B Clin Cytom; 2020 Jul; 98(4):328-335. PubMed ID: 31944572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A triple-probe FISH screening strategy for risk-stratified therapy of acute lymphoblastic leukaemia in low-resource settings.
    Parihar M; Singh MK; Islam R; Saha D; Mishra DK; Saha V; Krishnan S
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27366. PubMed ID: 30168245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
    Gupta DG; Varma N; Abdulkadir SA; Sreedharanunni S; Sachdeva MUS; Naseem S; Bose P; Binota J; Malhotra P; Khadwal A; Trehan A; Varma S
    Cancer; 2024 Mar; 130(5):713-726. PubMed ID: 37819686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia.
    Walter W; Shahswar R; Stengel A; Meggendorfer M; Kern W; Haferlach T; Haferlach C
    BMC Cancer; 2021 Aug; 21(1):886. PubMed ID: 34340673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IKZF1
    Stanulla M; Dagdan E; Zaliova M; Möricke A; Palmi C; Cazzaniga G; Eckert C; Te Kronnie G; Bourquin JP; Bornhauser B; Koehler R; Bartram CR; Ludwig WD; Bleckmann K; Groeneveld-Krentz S; Schewe D; Junk SV; Hinze L; Klein N; Kratz CP; Biondi A; Borkhardt A; Kulozik A; Muckenthaler MU; Basso G; Valsecchi MG; Izraeli S; Petersen BS; Franke A; Dörge P; Steinemann D; Haas OA; Panzer-Grümayer R; Cavé H; Houlston RS; Cario G; Schrappe M; Zimmermann M; ;
    J Clin Oncol; 2018 Apr; 36(12):1240-1249. PubMed ID: 29498923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120.
    Fazio G; Bresolin S; Silvestri D; Quadri M; Saitta C; Vendramini E; Buldini B; Palmi C; Bardini M; Grioni A; Rigamonti S; Galbiati M; Mecca S; Savino AM; Peloso A; Tu JW; Bhatia S; Borkhardt A; Micalizzi C; Lo Nigro L; Locatelli F; Conter V; Rizzari C; Valsecchi MG; Te Kronnie G; Biondi A; Cazzaniga G
    EBioMedicine; 2022 Sep; 83():104224. PubMed ID: 35985167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of leukemias with ETV6-ABL1 fusion.
    Zaliova M; Moorman AV; Cazzaniga G; Stanulla M; Harvey RC; Roberts KG; Heatley SL; Loh ML; Konopleva M; Chen IM; Zimmermannova O; Schwab C; Smith O; Mozziconacci MJ; Chabannon C; Kim M; Frederik Falkenburg JH; Norton A; Marshall K; Haas OA; Starkova J; Stuchly J; Hunger SP; White D; Mullighan CG; Willman CL; Stary J; Trka J; Zuna J
    Haematologica; 2016 Sep; 101(9):1082-93. PubMed ID: 27229714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment of atypical hyperdiploidy and IKZF1 deletions detected by SNP-microarray in high-risk Australian AIEOP-BFM B-cell acute lymphoblastic leukaemia cohort.
    Berry NK; Scott RJ; Sutton R; Law T; Trahair TN; Dalla-Pozza L; Ritchie P; Barbaric D; Enjeti AK
    Cancer Genet; 2020 Apr; 242():8-14. PubMed ID: 32058318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials.
    Eckert C; Parker C; Moorman AV; Irving JA; Kirschner-Schwabe R; Groeneveld-Krentz S; Révész T; Hoogerbrugge P; Hancock J; Sutton R; Henze G; Chen-Santel C; Attarbaschi A; Bourquin JP; Sramkova L; Zimmermann M; Krishnan S; von Stackelberg A; Saha V
    Eur J Cancer; 2021 Jul; 151():175-189. PubMed ID: 34010787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MD-ALL: an integrative platform for molecular diagnosis of B-acute lymphoblastic leukemia.
    Hu Z; Jia Z; Liu J; Mao A; Han H; Gu Z
    Haematologica; 2024 Jun; 109(6):1741-1754. PubMed ID: 37981856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia.
    van der Velden VH; de Launaij D; de Vries JF; de Haas V; Sonneveld E; Voerman JS; de Bie M; Revesz T; Avigad S; Yeoh AE; Swagemakers SM; Eckert C; Pieters R; van Dongen JJ
    Br J Haematol; 2016 Mar; 172(5):769-81. PubMed ID: 26898195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric B-lymphoblastic leukemia with RUNX1 amplification: clinicopathologic study of eight cases.
    Reichard KK; Kang H; Robinett S
    Mod Pathol; 2011 Dec; 24(12):1606-11. PubMed ID: 21822204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.
    Den Boer ML; van Slegtenhorst M; De Menezes RX; Cheok MH; Buijs-Gladdines JG; Peters ST; Van Zutven LJ; Beverloo HB; Van der Spek PJ; Escherich G; Horstmann MA; Janka-Schaub GE; Kamps WA; Evans WE; Pieters R
    Lancet Oncol; 2009 Feb; 10(2):125-34. PubMed ID: 19138562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Ghazavi F; De Moerloose B; Van Loocke W; Wallaert A; Helsmoortel HH; Ferster A; Bakkus M; Plat G; Delabesse E; Uyttebroeck A; Van Nieuwerburgh F; Deforce D; Van Roy N; Speleman F; Benoit Y; Lammens T; Van Vlierberghe P
    Oncotarget; 2016 Nov; 7(45):73769-73780. PubMed ID: 27650541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
    Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
    Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
    Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
    Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.